Cyetkバイオサイエンス社は2025年度の収益を予想し,8%のYOYが上昇,株式の9.7%を市場前において上回る. Cytek Biosciences forecasts $201M 2025 revenue, up 8% YoY, boosting shares 9.7% pre-market.

Cytek Biosciencesは2025年全年売上高を約1,200万米ドル,第4四半期の売上高を約6200万米ドルで,前年比8%増加,前四半期の19%の増加を示しています. Cytek Biosciences projects full-year 2025 revenue of about $201 million and fourth-quarter revenue of approximately $62 million, marking an 8% year-over-year increase and a 19% rise from the prior quarter. 同社は,事業分野を超え,収入の増加を図るための強い成果を表明した. The company cited strong performance across its business segments, driving continued revenue growth. 株式は前市場取引で9.7%上昇した. Shares rose 9.7% in pre-market trading. 2026年2月下旬に公式金融結果と2026年ガイドラインが期待される. Formal financial results and 2026 guidance are expected in late February 2026.